Crispr Therapeutics reported its first profit in 10 quarters on Wednesday, but CRSP stock whipsawed. In recent action, shares rose.
Crispr Stock Whipsaws As Wall Street Watches Its Gene-Editing Blockbuster Candidate
Feb 21, 2024
